Further Evaluation of Safety and Performance of the NEXUS Aortic Arch Stent Graft System and the Custom-Made NEXUS Multibranch™ Aortic Arch Stent Graft System

计划入组 70 人 · 首次发布于 2022 年 12 月 5 日

NEXUS™ Aortic Arch Stent Graft System First In Man Study

计划入组 18 人 · 首次发布于 2015 年 2 月 19 日

NEXUS Aortic Arch Clinical Study to Evaluate Safety and Effectiveness

计划入组 110 人 · 首次发布于 2020 年 7 月 15 日

Anti-CD34 mab-sirolimus (OrbusNeich)

ridaforolimus drug eluting stent

sirolimus eluting coronary stent

Arch Biopartners Inc.

Canada

Arch Therapeutics, Inc.

United States

Nexus Pharmaceuticals, LLC

United States

FDA Approves NEXUS Aortic Arch Stent Graft System for Minimally Invasive Treatment of Complex Aortic Disease

Endospan's NEXUS Aortic Arch Stent-Graft Shows Promising 30-Day Results in FDA TRIOMPHE Trial

Endospan Completes Enrollment in TRIOMPHE Trial for NEXUS Aortic Arch Stent Graft